SEP 8, 2026 · PHASE 1 TRIAL
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
ClinicalTrials.gov
Phase 1 trial registration with no posted results; study is actively recruiting and designed to establish safety and tolerability rather than efficacy.
Reported
Planned enrollment260
Trial phasePhase 1
Primary outcome measure—Phase 1aNumber of patients with dose-limiting toxic…